A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats

Conotte, Raphael; Colet, Jean-Marie

No full text

Article (Scientific journals)

A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats

Conotte, Raphael; Colet, Jean-Marie

2014 • In Toxicology and Applied Pharmacology, 276 (2), p. 147-156

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/20.500.12907/1477

PubMed
24582690

Files (0)Send to Details Statistics Bibliography Similar publications

Files

Full Text

No document available.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Research center :

UMHAP - Centre de Recherche UMONS-Ambroise Paré

Disciplines :

Pharmacy, pharmacology & toxicology
Radiology, nuclear medicine & imaging

Author, co-author :

Conotte, Raphael ; Université de Mons > Faculté de Médecine et de Pharmacie > Biologie humaine et Toxicologie

Colet, Jean-Marie ; Université de Mons > Faculté de Médecine et de Pharmacie > Biologie humaine et Toxicologie

Language :

English

Title :

A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats

Publication date :

28 February 2014

Journal title :

Toxicology and Applied Pharmacology

ISSN :

0041-008X

Publisher :

Elsevier, Atlanta, United States - New York

Volume :

276

Issue :

Pages :

147-156

Peer reviewed :

Peer Reviewed verified by ORBi

Research unit :

M125 - Biologie humaine et Toxicologie

Research institute :

R550 - Institut des Sciences et Technologies de la Santé

Available on ORBi UMONS :

since 28 February 2014

Statistics

Number of views

0 (0 by UMONS)

Number of downloads

0 (0 by UMONS)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Bando K., Kunimatsu T., Sakai J., Kimura J., Funabashi H. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats. J. Appl. Toxicol. 2011, 31:524-535. (http://www.ncbi.nlm.nih.gov/pubmed/1154879).
Beckonert O., Keun H.C., Ebbels T.M., Bundy J., Holmes E., et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2007, 2(11):2692-2703. (http://www.ncbi.nlm.nih.gov/pubmed/18007604).
Brouquet A., Andreou A., Vauthey J.N. The management of solitary colorectal liver metastases. Surgeon 2011, 9(5):265-272. (http://www.ncbi.nlm.nih.gov/pubmed/21843821).
Chen Z., Huo J.R. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth. J. Med. 2010, 68(6):252-260. (http://www.ncbi.nlm.nih.gov/pubmed/20558855).
Chojkier M. Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids. J. Hepatol. 2003, 39(3):437-446. (http://www.ncbi.nlm.nih.gov/pubmed/12927933).
Copple B.L., Banes A., Ganey P.E., Roth R.A. Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure. Toxicol. Sci. 2002, 65(2):309-318. (http://www.ncbi.nlm.nih.gov/pubmed/11812935).
DeLeve L.D., Shulman H.M., McDonald G.B. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin. Liver Dis. 2002, 22(1):27-42. (http://www.ncbi.nlm.nih.gov/pubmed/11928077).
DeLeve L.D., Wang X., Kanel G.C., Ito Y., Bethea N.W., et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 2003, 38(4):900-908. (http://www.ncbi.nlm.nih.gov/pubmed/14512877).
Gamble J.G., Lehninger A.L. Transport of ornithine and citrulline across the mitochondrial membrane. J. Biol. Chem. 1973, 248(2):610-618. (http://www.ncbi.nlm.nih.gov/pubmed/4684694).
Hasim A., Ali M., Mamtimin B., Ma J.Q., Li Q.Z., et al. Metabonomic signature analysis of cervical carcinoma and precancerous lesions in women by (1)H NMR spectroscopy. Exp. Ther. Med. 2012, 3(6):945-951. (http://www.ncbi.nlm.nih.gov/pubmed/22969997).
Helmy A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment. Pharmacol. Ther. 2006, 23(1):11-25. (11-25. http://www.ncbi.nlm.nih.gov/pubmed/16393276).
Kawada K., Hasegawa S., Murakami T., Itatani Y., Hosogi H., et al. Molecular mechanisms of liver metastasis. Int. J. Clin. Oncol. 2011, 16(5):464-472. (http://www.ncbi.nlm.nih.gov/pubmed/21847533).
Konopke R., Roth J., Volk A., Pistorius S., Folprecht G., et al. Colorectal liver metastases: an update on palliative treatment options. J. Gastrointest. Liver Dis. 2012, 21(1):83-91. (http://www.ncbi.nlm.nih.gov/pubmed/22457864).
Kumar S., DeLeve L.D., Kamath P.S., Tefferi A. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin. Proc. 2003, 78(5):589-598. (http://www.ncbi.nlm.nih.gov/pubmed/12744547).
Kumar B.S., Chung B.C., Kwon O.S., Jung B.H. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics. J. Appl. Toxicol. 2012, 32(7):505-520. (http://www.ncbi.nlm.nih.gov/pubmed/22131085).
Lindon J.C., Nicholson J.K. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu. Rev. Anal. Chem. 2008, 1:45-69. (http://www.ncbi.nlm.nih.gov/pubmed/20636074).
Lindon J.C., Holmes E., Nicholson J.K. Metabonomics techniques and applications to pharmaceutical research & development. Pharm. Res. 2006, 23(6):1075-1088. (http://www.ncbi.nlm.nih.gov/pubmed/16715371).
Liu Y., Huang R., Liu L., Peng J., Xiao B., et al. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy. J. Pharm. Biomed. Anal. 2010, 52(1):136-141. (http://www.ncbi.nlm.nih.gov/pubmed/20061116).
Lu C., Wang Y., Sheng Z., Liu G., Fu Z., et al. NMR-based metabonomic analysis of the hepatotoxicity induced by combined exposure to PCBs and TCDD in rats. Toxicol. Appl. Pharmacol. 2010, 248(3):178-184.
Nelson H., Petrelli N., Carlin A., Couture J., Fleshman J., et al. Guidelines 2000 for colon and rectal cancer surgery. J. Natl. Cancer Inst. 2001, (8):583-596. (http://www.ncbi.nlm.nih.gov/pubmed/11309435).
Nicholson J.K., Lindon J.C. Systems biology. Metabonomics Nat. 2008, 455(7216):1054-1056. (http://www.ncbi.nlm.nih.gov/pubmed/18948945).
Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002, 1(2):153-161. (http://www.ncbi.nlm.nih.gov/pubmed/12120097).
Nordlinger B., Sorbye H., Glimelius B., Poston G.J., Schlag P.M., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled 2008, 371(9617):1007-1016. (http://www.ncbi.nlm.nih.gov/pubmed/18358928.).
Robertson D.G. Metabonomics in toxicology: a review. Toxicol. Sci. 2005, 85(2):809-822. (http://www.ncbi.nlm.nih.gov/pubmed/15689416).
Rubbia-Brandt L., Audard V., Sartoretti P., Roth A.D., Brezault C., et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann. Oncol. 2004, (3):460-466. (http://www.ncbi.nlm.nih.gov/pubmed/14998849).
Schiffer E., Frossard J.L., Rubbia-Brandt L., Mentha G., Pastor C.M. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome. J. Surg. Oncol. 2009, 99(7):439-446. (http://www.ncbi.nlm.nih.gov/pubmed/19353590).
Shockcor J.P., Holmes E. Metabonomic applications in toxicity screening and disease diagnosis. Curr. Top. Med. Chem. 2002, 2:35-51.
Tang B., Ding J., Wu F., Chen L., Yang Y., et al. 1H NMR-based metabonomics study of the urinary biochemical changes in Kansui treated rat. J. Ethnopharmacol. 2012, 141(1):134-142. (http://www.ncbi.nlm.nih.gov/pubmed/22406398).
Timbrell J.A., Waterfield C.J., Draper R.P. Use of urinary taurine and creatine as biomarkers of organ dysfunction and metabolic perturbations. Comp. Haematol. Int. 1995, 5(2):112-119.
Warskulat U., Zhang F., Häussinger D. Taurine is an osmolyte in rat liver macrophages (Kupffer cells). J. Hepatol. 1997, 26(6):1340-1347.
Weik C., Warskulat U., Bode J., Peters-Regehr T., Häussinger D. Compatible organic osmolytes in rat liver sinusoidal endothelial cells. Hepatology 1998, 27(2):569-575. (http://www.ncbi.nlm.nih.gov/pubmed/9462659).
Wettstein M., Weik C., Holneicher C., Häussinger D. Betaine as an osmolyte in rat liver: metabolism and cell-to-cell interactions. Hepatology 1998, 27(3):787-793. (http://www.ncbi.nlm.nih.gov/pubmed/9500708).
Wettstein M., Peters-Regehr T., Kubitz R., Fischer R., Holneicher C. Release of osmolytes induced by phagocytosis and hormones in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278(2):G227-G233. (http://www.ncbi.nlm.nih.gov/pubmed/10666046).
Yamashita H., Itsuki A., Kimoto M., Hiemori M., Tsuji H. Acetate generation in rat liver mitochondria; acetyl-CoA hydrolase activity is demonstrated by 3-ketoacyl-CoA thiolase. Biochim. Biophys. Acta 2006, 1761(1):17-23. (http://www.ncbi.nlm.nih.gov/pubmed/16476568).
Yang Y.C., Crowder J., Wardle N.J., Yang L., White K.N., et al. 1H NMR study of monocrotaline and its metabolites in human blood. Food Chem. Toxicol. 2011, 49(11):2793-2799. (http://www.ncbi.nlm.nih.gov/pubmed/21843583).
Yee S.B., Hanumegowda U.M., Copple B.L., Shibuya M., Ganey P.E., et al. Endothelial cell injury and coagulation system activation during synergistic hepatotoxicity from monocrotaline and bacterial lipopolysaccharide coexposure. Toxicol. Sci. 2003, 74(1):203-214. (http://www.ncbi.nlm.nih.gov/pubmed/12730616).
Zhang L., Ye Y., An Y., Tian Y., Wang Y., et al. Systems responses of rats to aflatoxin B1 exposure revealed with metabonomic changes in multiple biological matrices. J. Proteome Res. 2011, 10(2):614-623. (http://www.ncbi.nlm.nih.gov/pubmed/21080729).